相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。RRM2 induces NF-κB-dependent MMP-9 activation and enhances cellular invasiveness
Mark S. Duxbury et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2007)
ERCC1 and RRM1 gene expressions but not EGFR are predictive of shorter survival in advanced non-small-cell lung cancer treated with cisplatin and gemcitabine
P. Ceppi et al.
ANNALS OF ONCOLOGY (2006)
Vinorelbine plus cisplatin versus docetaxel plus gemcitabine in advanced non-small-cell lung cancer: A phase III randomized trial
V Georgoulias et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Ribonucleotide reductase messenger RNA expression and survival in gemcitabine/cisplatin-treated advanced non-small cell lung cancer patients
R Rosell et al.
CLINICAL CANCER RESEARCH (2004)
Retrovirally mediated RNA interference targeting the M2 subunit of ribonucleotide reductase: A novel therapeutic strategy in pancreatic cancer
MS Duxbury et al.
SURGERY (2004)
RNA interference targeting focal adhesion kinase enhances pancreatic adenocarcinoma gemcitabine chemosensitivity
MS Duxbury et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2003)
Transcripts in pretreatment biopsies from a three-arm randomized trial in metastatic non-small-cell lung cancer
R Rosell et al.
ONCOGENE (2003)
Paclitaxel plus carboplatin versus gemcitabine plus paclitaxel in advanced non-small-cell lung cancer: A phase III randomized trial
P Kosmidis et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Comparison of four chemotherapy regimens for advanced non-small-cell lung cancer
JH Schiller et al.
NEW ENGLAND JOURNAL OF MEDICINE (2002)
Prognostic significance of molecular genetic aberrations on chromosome segment 11p15.5 in non-small-cell lung cancer
G Bepler et al.
JOURNAL OF CLINICAL ONCOLOGY (2002)
Platinum-based and non-platinum-based chemotherapy in advanced non-small-cell lung cancer: a randomised multicentre trial
V Georgoulias et al.
LANCET (2001)
Combined paclitaxel and gemcitabine as first-line treatment in metastatic non-small cell lung cancer:: a multicentre phase II study
JY Douillard et al.
BRITISH JOURNAL OF CANCER (2001)
A ribonucleotide reductase gene involved in a p53-dependent cell-cycle checkpoint for DNA damage
H Tanaka et al.
NATURE (2000)
分享论文
